Sangamo BioSciences | Spese Di Vendita E Di Amministrazione





Spese Di Vendita E Di Amministrazione Cambiamento Data
Alaunos Therapeutics USD 585K 260K 2025-09
Alnylam Pharmaceuticals USD 262.59M 60.72M 2025-09
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
Amgen USD 1.94B 237M 2025-12
Bayer EUR 3.4B 140M 2025-09
BioCryst Pharmaceuticals USD 80.47M 15.39M 2024-12
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 223.42M 8.86M 2025-09
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.33M 50K 2025-09
CSL USD 727M 453M 2025-06
Gilead Sciences USD 1.35B 6M 2025-09
GlaxoSmithKline GBP 2.68B 518M 2025-12
Grifols EUR 333.1M 157M 2025-09
Ionis Pharmaceuticals USD 86.56M 4.04M 2025-09
J&J USD 6.75B 831M 2025-12
Karyopharm Therapeutics USD 27.19M 442K 2024-12
Merck USD 2.85B 215M 2025-12
Novartis USD 3.31B 134M 2025-09
Omeros USD 11.32M 2.48M 2024-09
Pfizer USD 4.08B 894M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sanofi EUR 2.75B 455M 2025-12
Sarepta Therapeutics USD 77.11M 7.22M 2025-09
Tectonic Therapeutic USD 4.96M 190K 2025-09
Ultragenyx Pharmaceutical USD 86.62M 26K 2025-09
Vertex Pharmaceuticals USD 445.1M 20.5M 2025-09


Sangamo BioSciences Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.